Searched for
RELIANCE LIFESCIENCES
Stocks in news: RIL, Coal India, IDFC First Bank, Zydus Life, ONGCMarkets traded subdued with the India VIX correcting nearly 15% this week, though this hasn't significantly impacted benchmark index moveme...- Ahead of Market: 10 things that will decide stock market action on ThursdayBenchmark indices closed marginally higher on Wednesday, led by gains in banking and auto shares, while IT and FMCG stocks capped advances....
- Ahead of Market: 10 things that will decide stock market action on FridayBSE Sensex and Nifty 50 extended gains for a second session, led by banking, metal and pharma stocks despite IT weakness. Analysts flagged ...
- Ahead of Market: 10 things that will decide stock market action on ThursdayIndian stock markets saw a strong upward trend on Wednesday. The Nifty 50 and Sensex both closed higher, driven by gains in auto, FMCG, and...
- What war? Smallcap stocks defy Middle East tensions with up to 56% gains in 2 months as Nifty slidesDespite Middle East tensions and a sliding Nifty50, India's smallcap stocks have surged up to 56% in two months. While institutional desks ...
- Sun Pharma to acquire Organon for $11.75 billion in India’s biggest pharma dealSun Pharma, led by Dilip Shanghvi, has agreed to acquire US-based Organon in an all-cash deal worth $11.75 billion, marking the largest acq...
- Ahead of Market: 10 things that will decide stock market action on TuesdayThe Nifty 50 and BSE Sensex rebounded on broad-based buying led by pharma, IT, auto and metals. Volatility eased, while analysts signalled ...
- Most hated stocks: FIIs dumping these 146 companies without a break for 4 straight quarters. Do you own any?Foreign institutional investors have been consistently selling shares in 146 Indian companies for four consecutive quarters. This selling s...
- Airtel, RIL among 7 largecap stocks that hit 52-week highReliance Industries, a conglomerate with diverse interests ranging from petrochemicals to telecommunications, achieved a 52-week high of Rs...
- Stocks in news: Ajanta Pharma, HAL, Poonawala Fincorp, Wipro, Gokaldas ExportsThe board of REC has approved fundraising of up to Rs 1.2 lakh crore under different debt instruments for financial year 2023-24. The funds...
- Stocks in news: Delhivery, Zydus Life, Paytm, SBI, NTPC, RILJapanese multinational conglomerate Softbank Group is looking to sell shares worth Rs 600 crore in Delhivery through block deals on Wednesd...
- Supriya Lifescience IPO closes with over 71x subscriptionsThe ₹700 crore initial public offering of pharmaceutical ingredients supplier Supriya Lifescience was subscribed 71.47 times on Monday, the...
- YES Bank sells 17 lakh shares of Reliance CapitalThe private sector lender sold 16,78,900 shares at an average price of Rs 16.26 apiece.
- Stock market update: 52 stocks hit 52-week lows on NSEAmong the stocks that touched their 52-week lows were RBL Bank, Alembic and Cox & Kings.
- Stock market update: 138 stocks hit 52-week lows on NSEDomestic benchmark index NSE Nifty was trading 31.60 points up at 11,954.30.
- Biosimilar drugs are priced too high and do little to improve accessibility: DoctorsBiosimilar drugs are follow-on biologics that have nearly the same efficacy as the original drug and used to treat cancer or autoimmune dis...
- Reliance Lifesciences launches world's first biosimilar used to treat advanced cancersIn 2014, Reliance had entered into a similar arrangement with Torrent Pharma to sell copies of three drugs -- rituximab, adalimumab and cet...
- Forget May 16, mkt-savvy politicos already winner as scrips upOutcome of their performance will be known on May 16 but scores of LS aspirants are sitting on hefty returns courtesy their investments in ...
- US pvt equity firm buys over 30% in Nectar LifesciencesUS-based private equity firm — New Silk Route Partners (NSR) — has picked up a little over 30% stake in Chandigarh-based listed pharma comp...
- Reliance LifeScience picks 74% in GeneMedixReliance LifeScience on Wednesday announced the acquisition of a 74% equity stake (1.1 billion shares) in the UK-based biotech firm.
Load More
